Schedule 13G ownership disclosure

PHIO PHARMACEUTICALS CORP

Common stock, par value $0.0001 per share · CUSIP: 71880W501

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mitchell P. Kopin

    Shares: 430,000.00 · Class: 7.0%

  • Daniel B. Asher

    Shares: 430,000.00 · Class: 7.0%

  • Intracoastal Capital LLC

    Shares: 430,000.00 · Class: 7.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-107723
Form type
SCHEDULE 13G/A
Filer
INTRACOASTAL CAPITAL, LLC
CIK
CIK 1646799
Filed
Nov 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub